Compare EW & AMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EW | AMP |
|---|---|---|
| Founded | 1958 | 1894 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2B | 42.4B |
| IPO Year | 1999 | 2008 |
| Metric | EW | AMP |
|---|---|---|
| Price | $79.48 | $437.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | $96.47 | ★ $560.20 |
| AVG Volume (30 Days) | ★ 4.2M | 594.4K |
| Earning Date | 04-22-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.47% |
| EPS Growth | N/A | ★ 9.77 |
| EPS | 1.83 | ★ 36.28 |
| Revenue | $6,067,600,000.00 | ★ $18,911,000,000.00 |
| Revenue This Year | $13.39 | $2.28 |
| Revenue Next Year | $9.78 | $4.19 |
| P/E Ratio | $43.56 | ★ $12.04 |
| Revenue Growth | ★ 11.55 | 5.49 |
| 52 Week Low | $65.94 | $396.14 |
| 52 Week High | $87.89 | $550.18 |
| Indicator | EW | AMP |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 38.47 |
| Support Level | $74.46 | $430.57 |
| Resistance Level | $82.64 | $509.70 |
| Average True Range (ATR) | 2.09 | 10.26 |
| MACD | -0.49 | 1.32 |
| Stochastic Oscillator | 15.37 | 27.55 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating income from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third key segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.